Adoram Therapeutics
Latest round
- Seed
Last raised
- Oct 2024
Total raised
- $0.1M
Investors
- 1
About Adoram Therapeutics
Founded in 2022 by co-founders David Pejoski, Hesham Hamed, and Leonardo Scapozza and based in Geneva, Switzerland, Adoram Therapeutics SA is engaged in developing allosteric molecular modes of action-based therapies to treat patients with cancer. Adoram Therapeutics offers A2AR NAM (negative allosteric modulator of the adenosine 2A receptor), designed to augment the anti-tumour immune response in patients suffering from various solid tumours. This product is in the preclinical testing stage. Additionally, the company offers A2AR PAM (positive allosteric modulator), a preclinical asset in the development of inflammatory and autoimmune disorders. The company’s targeted therapeutic solutions primarily serve oncology patients who are unresponsive to existing immunotherapies or lack access to complex therapies.
Who invested in Adoram Therapeutics
1 investor across 1 round
See all investors in Adoram Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Oct 25, 2024
Amount
$0.1M
Investors
Questions about Adoram Therapeutics
Who invested in Adoram Therapeutics?
Adoram Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Adoram Therapeutics raised?
Adoram Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Adoram Therapeutics last raise money?
Adoram Therapeutics's most recent round on record is a Seed, in Oct 2024.
What does Adoram Therapeutics do?
Founded in 2022 by co-founders David Pejoski, Hesham Hamed, and Leonardo Scapozza and based in Geneva, Switzerland, Adoram Therapeutics SA is engaged in developing allosteric molecular modes of action-based therapies to treat patients with cancer.
Where is Adoram Therapeutics headquartered?
Adoram Therapeutics is headquartered in Switzerland.
Which VCs invest in companies like Adoram Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Adoram Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Adoram Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.